Severe asthma in the biologic era
Five biologic options later, the question in severe asthma is increasingly about phenotyping and switching.
Severe asthma now has multiple effective biologics. The clinical picture has moved from "do biologics work?" to "how do you choose between them, and when do you switch?" That is a phenotyping and real-world-evidence story.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.
Related
← Back to Signals
Published by PatientSpotlight, by PanaceaIntel.